Showing 5411-5420 of 20465 results for "".
- LEO Pharma Finalizes Acquisition of Spevigo® for Rare Dermatologic Diseaseshttps://reachmd.com/news/leo-pharma-finalizes-acquisition-of-spevigo-for-rare-dermatologic-diseases/2483600/LEO Pharma has officially completed its acquisition of Spevigo® (spesolimab) from Boehringer Ingelheim, according to a press release from the manufacturer. The purchase represents the c
- FDA Approves Remibrutinib for Adults With CSUhttps://reachmd.com/news/fda-approves-remibrutinib-for-adults-with-csu/2483590/The US Food and Drug Administration (FDA) has approved remibrutinib (Rhapsido, Novartis) as the first oral Bruton’s tyrosine kinase (BTK) inhibitor for the treatment of chronic spontaneous urticaria (CSU) in adults whose symptoms persist despite H1 antihistamine the
- Harnessing AI: Revolutionizing Surgical Stapling in Bariatric Surgeryhttps://reachmd.com/news/harnessing-ai-revolutionizing-surgical-stapling-in-bariatric-surgery/2483577/Within the rapidly evolving field of metabolic and bariatric surgery, surgical stapling is undergoing a significant transformation powered by artificial intelligence (AI). This integration is enhancing surgical precision with potential to improve patient outcomes, according to emerg
- Unveiling the Long-term Risks of Childhood Sunburns on Skin Cancer Developmenthttps://reachmd.com/news/unveiling-the-long-term-risks-of-childhood-sunburns-on-skin-cancer-development/2483584/The legacy of childhood sunburns continues to unfold across a lifetime, leaving indelible marks that heighten the risk of skin cancer, especially cSCC. Dermatologists and pediatricians must emphasize the lasting implications of UV damage witnessed in an era of growing skin cancer in
- The Elusive Persistence of HIV and Yellow Fever Virushttps://reachmd.com/news/the-elusive-persistence-of-hiv-and-yellow-fever-virus/2483580/Viruses, like HIV and Yellow Fever Virus, continuously challenge our understanding, defying immune defenses and existing eradication efforts. This persistent struggle drives ongoing research and therapeutic innovation. Understanding the persistence mechanisms of HIV alongside the ac
- Unraveling the Role of DIORA1 in Autoimmune Rheumatic Diseaseshttps://reachmd.com/news/unraveling-the-role-of-diora1-in-autoimmune-rheumatic-diseases/2483575/Early laboratory findings suggest DIORA1 may influence cell motility relevant to inflammatory processes, but any relevance to rheumatoid arthritis or lupus remains hypothetical and requires validation in peer‑reviewed studies, suggesting potential avenues for therapeutic exploration
- Preserving Vision in Aging: The Essential Roles of Regular Eye Examshttps://reachmd.com/news/preserving-vision-in-aging-the-essential-roles-of-regular-eye-exams-and-nutrition/2483582/Maintaining vision in aging adults is a continuous healthcare challenge, with the importance of proactive care growing as our population ages. In practice, many professional groups advise comprehensive eye examinations annually or every 1–2 years for older adults, underscoring the n
- Lung Cancer Treatment: Evaluating Surgery, Radiation, and Novel Therapieshttps://reachmd.com/news/lung-cancer-treatment-evaluating-surgery-radiation-and-novel-therapies/2483578/As lung cancer persists as a formidable adversary in oncology, the clinical landscape for Non-Small Cell Lung Cancer (NSCLC) treatment is rapidly evolving. With the rising prominence of stereotactic body radiation therapy (SBRT) for medically inoperable early-stage disease—as endors
- CollPlant Advances Light-Activated Regenerative Filler Toward Clinical Trialshttps://reachmd.com/news/collplant-advances-light-activated-regenerative-filler-toward-clinical-trials/2483589/CollPlant Biotechnologies has announced the completion of a nonclinical program supporting the development of its photocurable dermal filler, which combines hyaluronic acid with a modified form of recombinant human collagen (rhCollagen). The company plans to advanc
- HIV-Related Lymphomas and the COVID-19 Pandemichttps://reachmd.com/news/hiv-related-lymphomas-and-the-covid-19-pandemic/2483568/The management of HIV-related lymphomas has become increasingly complex due to COVID-19, necessitating a shift in treatment protocols to minimize viral exposure while managing cancer progressio